Managing Risks and Benefits: Anticoagulation Use for Patients with Advanced Kidney Disease: Brooklyn Hospital Only
Target Audience
All pharmacists
Learning Objectives
At the completion of this activity, the participant will be able to:
Define the pharmacokinetic parameters of anticoagulants when used in patients with advanced kidney disease
Identify pathophysiology and risk factors for bleeding and thrombosis in patients with advanced kidney disease
State guideline recommendations regarding anticoagulation in patients with advanced kidney disease
Describe literature surrounding anticoagulation use and preferred dosing strategies in patients with advanced kidney disease
Kelley Greene, PGY2 Ambulatory Care Pharmacy Resident, PharmD.
Kelley Greene is a current PGY1 Ambulatory Care Resident at the Brooklyn Hospital Center. She graduated from the University of Connecticut School of Pharmacy in 2023 and went on to complete her PGY1 Pharmacy Residency at BronxCare in the Bronx, NY.
ACPE UAN 0042-0000-24-076-L01-P
Available Credit
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.